Lincoln Ventures agrees to acquire Aegis Medical Innovations in all-share deal

• Lincoln Ventures will acquire all 36,823,916 Aegis Medical Innovations shares for 3.22 common shares per Aegis share.
• Aegis shareholders will own 60% of the resulting company, which will be renamed Sierra Medical Innovations.
• Financing comprises a CAD 300,000 bridge placement at CAD 0.05 per share and CAD 6.95 million concurrent financing.
• Closing is targeted for January 31, 2027, subject to financing completion and required approvals.
• Up to CAD 1 million will go directly to Aegis to accelerate European clinical trials and manufacturing of its cardiovascular device.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lincoln Ventures Ltd. published the original content used to generate this news brief via Newsfile (Ref. ID: 202611031155NEWSFILECNPR____20261103_322293_1) on November 03, 2026, and is solely responsible for the information contained therein.